Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

36.86
Delayed Data
As of Sep 23
 -0.66 / -1.76%
Today’s Change
31.08
Today|||52-Week Range
80.25
-52.00%
Year-to-Date
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
Novartis (NVS) Presents Positive Data on Cardiovascular Drug
Sep 19 / Zacks.com - Paid Partner Content
AstraZeneca Withdraws Cediranib Marketing Application in EU
Sep 22 / Zacks.com - Paid Partner Content
Novartis Reports Positive Phase II Data on Migraine Drug
Sep 16 / Zacks.com - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content
Epizyme Receives Milestone from Glaxo for Lymphoma Drug
Sep 16 / Zacks.com - Paid Partner Content
Adamas (ADMS) Parkinson's Disease Drug Positive in Phase III
Sep 21 / Zacks.com - Paid Partner Content
Roche Ocrevus Positive in Phase III Multiple Sclerosis Trials
Sep 15 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Gets Favorable CHMP Opinion for Olaratumab
Sep 19 / Zacks.com - Paid Partner Content
Shire's Immunodeficiency Treatment Cuvitru Gets FDA Approval
Sep 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close37.52
Today’s open37.60
Day’s range36.82 - 38.25
Volume678,282
Average volume (3 months)814,797
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-58.53%
Earnings growth (next 5 years)+80.00%
Revenue growth (last year)+25.97%
P/E ratioNM
Price/Sales12.74
Price/Book6.22

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-1.22-3.18%
CEMPCempra Inc+0.61+2.48%
PTLAPortola Pharmaceutic...-0.52-2.19%
SUPNSupernus Pharmaceuti...+0.15+0.58%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.04
Annual revenue (last year)$249.0M
Annual profit (last year)$1.9M
Net profit margin0.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David M. Stack
President
James S. Scibetta
Corporate headquarters
Parsippany, New Jersey

Forecasts

Search for Jobs